Passkey Therapeutics
PrivateLast Round
Seed
Oct 22, 2024
Total Funding Raised
$20M
Company Overview
Passkey Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Seed round in October 2024.
Passkey Therapeutics is a biotechnology company developing Synergistic Multifunctional Therapeutics (SMThs) designed to address complex diseases by targeting rare combinations of proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Passkey Therapeutics Comparables
Compare Passkey Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Earendil Labs | 80% | |
| Model Medicines | 78% | |
| Iambic Therapeutics | 77% |
For institutional investors. Book with your work email.
Passkey Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Passkey Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wireframe Ventures | Seed |
| Innovation Endeavors | Seed |
| Breakout Ventures | Seed |
| Alexandria Venture Investments | Seed |
| GRIDS Capital | Seed |
| Bison Ventures | Seed |
Passkey Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Passkey Therapeutics's valuation, stock price, and market status.
Is Passkey Therapeutics a public or private company?
Passkey Therapeutics is a private company.
What is the current stock price of Passkey Therapeutics?
Passkey Therapeutics is a private company, so its shares have no public market price. Caplight tracks Passkey Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Passkey Therapeutics worth (valuation)?
Valuation information for Passkey Therapeutics is not publicly available.
Can I buy Passkey Therapeutics stock?
Passkey Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Passkey Therapeutics's last funding round?
Passkey Therapeutics's most recent funding round was Seed on October 22, 2024.
Who are the main investors in Passkey Therapeutics?
Key investors in Passkey Therapeutics include Breakout Ventures.
Will Passkey Therapeutics IPO soon?
No public IPO plans have been announced for Passkey Therapeutics.
How can I track Passkey Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Passkey Therapeutics's shares on secondary markets.